EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the blast cell sensitivity to cytostatic drugs in various acute leukemia types and their clinical implications


Neoplasma (Bratislava) 31(3): 291-298
Differences in the blast cell sensitivity to cytostatic drugs in various acute leukemia types and their clinical implications
In 80 patients with AML [acute myeloblastic leukemia], ALL [acute lymphocytic leukemia], BC-CML [blast crisis of chronic myelocytic leukemia] and other proliferative blood diseases, the sensitivity of blast cells to cytostatics (vincristine, cytosine arabinoside, daunorubicin, l-asparaginase, hydrocortisone) was determined. The studies were made with the use of liquid scintillation measuring the inhibition of 3H-TdR [thymidine] incorporation induced by the cytostatics tested. The method makes it possible to demonstrate individual reactivity of acute leukemia blasts to cytostatics. Variations in the individual sensitivity to cytostatics were mostly seen in AML and BC-CML, less often in acute lymphocytic leukemia.


Accession: 005151121

PMID: 6738754



Related references

Differences in the blast cells sensitivity to cytostatic drugs in various acute leukemia types and their clinical implications. Neoplasma 31(3): 291-298, 1984

Study of the blast cell sensitivity to cytostatic agents in acute leukemia by the radioisotope method. Polski Tygodnik Lekarski 35(15): 535-538, 1980

Decreased sensitivity of cytostatic drugs in glucocorticoid receptor free acute myeloid leukemia cells clinical and experimental observations. Acta Paediatrica Hungarica 31(2): 223-232, 1991

Investigations of the sensitivity to cytostatic agents of blast cells in acute leukemia by the radio isotope method. Polski Tygodnik Lekarski 35(15): 535-538, 1980

Results of the treatment of acute leukemia in relation to the sensitivity of leukemia cells to cytostatic drugs. Vrachebnoe Delo: 86-88, 1988

In vitro investigation of the blast cells sensitivity to cytostatic drugs. Dokladi na B"lgarskata Akademiya na Naukite 47(4): 129-131, 1994

Action of colony-stimulating factors on effectiveness of cytostatic drugs in acute myeloblastic leukemia Laboratory and clinical studies. Gematologiya i Transfuziologiya 44(1): 34-37, Jan -Feb, 1999

Decreased sensitivity of cytostatic drugs in glucocorticoid receptor-free acute myeloid leukaemia cells. Clinical and experimental observations. Acta Paediatrica Hungarica 31(2): 223-231, 1991

The primary product of DNA transcription in the blast cell of acute leukemia. Its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia. Bollettino Dell'istituto Sieroterapico Milanese 57(3): 325-333, 1978

The sensitivity of blast cell to chemotheraty agents in vitro as a prognostic factor in childhood acute leukemia. Leukemia (Basingstoke) 17(3): 679, March, 2003